Newsletter Subject

Most exciting Alzheimer’s breakthrough yet

From

alsearsmd.com

Email Address

alsearsmd@send.alsearsmd.com

Sent On

Thu, Nov 2, 2023 10:22 PM

Email Preheader Text

While it’s devastating to see patients who are suffering from Alzheimer’s at my wellness c

While it’s devastating to see patients who are suffering from Alzheimer’s at my wellness clinic [Click here](1770d7/ct0_0/1/ms?sid=TV2%3AarUs31fhY) to view this message in your browser | [Click here](1770d7/l-002e/zout?sid=TV2%3AarUs31fhY) to stop receiving our messages [] [] Al Sears, MD 11905 Southern Blvd. Royal Palm Beach, FL 33411 [] November 2, 2023 [] Reader, While it’s devastating to see patients who are suffering from Alzheimer’s at my wellness clinic, I’m fortunate enough to offer the latest breakthrough therapies that can help treat this memory-destroying disease. Including a transcranial helmet that beams infrared light – easily and painlessly – directly into the brain. According to researchers, this cutting-edge therapy could be a “game changer” in the fight against Alzheimer’s. It works through a process called “photobiomodulation” (tPBM), where pulses of infrared light are directed deep into the brain. [beyonce] During tPBM therapy, patients can watch TV, sleep, or simply relax. In the study, 14 volunteers aged 45 and older wore the transcranial helmet for six minutes twice a day for a month. Infrared light was beamed through the helmet’s diodes. A second group received a sham treatment. Both groups were given a set of memory tests before and after treatment. After 30 days, the group that used transcranial photobiomodulation therapy noted significant improvement in performance in motor function and brain processing speed. They also had “rapid improvement in memory performance,” according to the research team. Let me explain… Your brain works with chemicals and bioelectrical impulses. Big Pharma’s therapies attempt to change your brain’s chemical responses with drugs – and make massive profits along the way – but too often do more damage than good. Instead, tPBM uses laser light to modulate the frequencies of bioelectrical impulses, specifically in parts of the brain that have been damaged by the buildup of rogue protein clusters and tangles and suffered oxygen and nutrient deprivation. Using mouse models, scientists recently discovered that electrical oscillations generated by the brain’s neural circuits are disrupted in Alzheimer’s disease. Now, researchers working with human patients have found that restoring these oscillations can activate the brain’s immune system without drugs and clear out the rogue proteins – without any side effects at all.1 This discovery marks an enormous breakthrough in Alzheimer’s treatment and, for the first time, provides proof and genuine hope that the disease can be reversed. A recent review published in 2021 in the Journal of Alzheimer´s Disease reviewed 36 published articles – 10 of which included studies on human subjects. Remarkably, all these studies concluded beneficial clinical results in the lives of EVERY study participant.2 On top of that, researchers highlighted that the intervention was free of side effects and “remarkably” easy to use. Here are just a few … - A trial published in the journal Aging and Disease compared the effects of tPBM therapy administered twice daily for six minutes during eight weeks against a placebo therapy. After seven days, the study group reported improved sleep quality. And after three weeks of tPBM therapy, patients experienced less anxiety, improved mood and energy, as well as significantly improved cognitive function.3 - In another clinical trial, 32 dementia patients who received tPBM had significantly improved cognitive function compared with a control group. Quality of life and independence were also noted in the daily lives of the subjects. Researchers said family caregivers also benefited by dramatically reducing their care burden.4 - In 2022, a randomized trial on 53 Alzheimer´s disease patients reported the effects of 40 tPBM sessions over a period of eight weeks. On top of improved general cognitive functions, patients showed faster task execution and longer attention spans. 5 Transcranial photobiomodulation works by allowing the brain to clear out rogue protein debris. This includes breaking down the chemical substance of the amyloid proteins... improving the flow of cerebrospinal fluid, which brings more life-giving oxygen into the brain... and triggering the release of nitric oxide, which widens the brain’s lymphatic vessels so that more toxins can be flushed out. As a result, brain cells are quickly freed and energized, which allows for greater connectivity between different parts of the brain, which in turn leads to cognitive and functionality improvement in patients, such as memory, motor function, and processing skills. Incredibly, all study results published have been consistently positive. What happens during tPBM therapy Getting transcranial photobiomodulation therapy couldn’t be easier… At the Sears Institute for Anti-Aging Medicine, we help dementia patients using both a transcranial helmet and a nasal tPBM device. Both are non-invasive and painless. The specially designed helmet emits specific lengths of red and near-infrared light to targeted zones of your brain. The nasal tPBM device involves clipping a small laser diode or LED bilaterally to the nose. During the therapy session, patients can watch TV or a movie, sleep, or simply relax. To Your Good Health, Al Sears, MD, CNS --------------------------------------------------------------- References: - Traikapi A and Konstantinou N. Gamma Oscillations in Alzheimer’s Disease and Their Potential Therapeutic Role Front. Syst. Neurosci., 13 December 2021. - Salehpour F, et al “Photobiomodulation Therapy for Dementia: A Systematic Review of Pre-Clinical and Clinical Studies.” Journal of Alzheimer's disease : JAD, 83(4), 1431–1452. 2021 - Nizamutdinov D, et al. “Transcranial Near Infrared Light Stimulations Improve Cognition in Patients with Dementia.” Aging Dis. 2021. Jul 1;12(4):954-963. - Kheradmand A, et al. “Therapeutic Effects of Low-Level Laser Therapy on Cognitive Symptoms of Patients with Dementia: A Double-Blinded Randomized Clinical Trial.” Photobiomodul Photomed Laser Surg. 2022 Sep;40(9):632-638. - Blivet G, et al. “A Randomized, Double-Blind, and Sham-Controlled Trial of an Innovative Brain-Gut Photobiomodulation Therapy: Safety and Patient Compliance.” J Alzheimers Dis. 2022;90(2):811-822. --------------------------------------------------------------- alsearsmd@send.alsearsmd.com [Preferences | Unsubscribe](1770d7/l-002e/zout?sid=TV2%3AarUs31fhY) 11905 Southern Blvd., Royal Palm Beach, Florida 33411, United States

Marketing emails from alsearsmd.com

View More
Sent On

31/05/2024

Sent On

31/05/2024

Sent On

30/05/2024

Sent On

29/05/2024

Sent On

28/05/2024

Sent On

27/05/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2024 SimilarMail.